Shark Cartilage Calcium

Shark cartilage calcium is derived from the dried, powdered cartilage of sharks and contains bioactive glycoproteins, proteoglycans, and calcium-rich hydroxyapatite as its primary compounds. Its proposed mechanisms center on angiogenesis inhibition via anti-angiogenic proteins such as sphyrnastatin and AE-941, alongside chondroitin sulfate-mediated anti-inflammatory signaling.

Origin & History

Shark Cartilage Calcium is a mineral-rich supplement derived from the calcified cartilage of shark endoskeletons, containing 10-20% calcium by weight alongside phosphorus, proteins, and mucopolysaccharides. It is produced through mechanical homogenization in water at 0-40°C, enzymatic cleaning with proteolytic enzymes at pH 8.5, and ultrafiltration to retain components under 500 kDa.

Historical & Cultural Context

No traditional or historical medicinal uses were documented in the available research. Modern interest in shark cartilage calcium emerged in the 1990s following processing patents for nutritional supplements targeting anti-tumor and immune effects.

Health Benefits

• Anti-angiogenic effects demonstrated in preclinical studies (evidence quality: preliminary - no human trials cited) • Anti-tumor proliferation activity shown in vitro and in vivo animal models (evidence quality: preliminary) • Anti-inflammatory properties identified in fractionated extracts (evidence quality: preliminary) • Anti-collagenolytic effects observed in laboratory studies (evidence quality: preliminary) • Immune system stimulation attributed to mucopolysaccharides content (evidence quality: preliminary)

How It Works

Shark cartilage contains sphyrnastatin-1 and sphyrnastatin-2, proteins that inhibit vascular endothelial growth factor (VEGF) binding and suppress neovascularization by blocking endothelial cell proliferation and migration. Chondroitin sulfate fractions modulate NF-κB signaling pathways, reducing pro-inflammatory cytokine expression including IL-1β and TNF-α. The hydroxyapatite-bound calcium fraction contributes to bone mineral density support by supplying bioavailable calcium phosphate for osteoblast matrix mineralization.

Scientific Research

No human clinical trials, RCTs, or meta-analyses for shark cartilage calcium were identified in the available research. One source mentions that aqueous extracts and powdered preparations are under clinical investigation for antitumor potential, but study details including design, sample size, and outcomes remain unpublished.

Clinical Summary

Preclinical in vitro and animal studies have demonstrated anti-tumor and anti-angiogenic activity from shark cartilage extracts, including the standardized product AE-941 (Neovastat), but these findings have not translated consistently to human outcomes. A Phase III randomized controlled trial of AE-941 in non-small cell lung cancer (n=379) published in the Journal of the National Cancer Institute (2007) found no statistically significant improvement in survival versus placebo. Smaller open-label studies in osteoarthritis populations reported modest symptomatic relief at doses of 500–4,500 mg/day, but lacked adequate controls and blinding. Overall, the human clinical evidence for shark cartilage calcium across all proposed indications remains insufficient to support efficacy claims.

Nutritional Profile

Shark cartilage calcium is primarily a protein-mineral matrix. Protein content is high, typically 30–60% by dry weight, composed largely of type II collagen and glycosaminoglycans (GAGs) including chondroitin sulfate (10–25% by weight). Calcium constitutes approximately 10–20% of dry weight, present as calcium phosphate (hydroxyapatite) embedded in the cartilaginous matrix. Phosphorus is present at roughly 5–10% by dry weight, maintaining a Ca:P ratio of approximately 2:1. Contains trace minerals including magnesium (0.2–0.5%), zinc, manganese, and iron in minor quantities. Bioactive compounds include chondroitin sulfate (~100–250 mg per typical serving), squalamine (trace anti-angiogenic aminosterol), and various low-molecular-weight peptides with potential bioactivity. The calcium bioavailability is moderate — the hydroxyapatite form is generally considered to have comparable or slightly lower absorption than calcium carbonate (~25–35% absorption rate), though the protein matrix may modestly enhance uptake via peptide-mediated transport. Collagen-derived peptides (primarily proline- and hydroxyproline-rich sequences) may offer additional bioactivity. Contains no significant fat, fiber, or carbohydrate content. Negligible vitamin content. Note: as a marine-derived product, trace levels of heavy metals (mercury, cadmium, arsenic, lead) may be present depending on source species and processing; quality-controlled products should test below regulatory thresholds. Mucopolysaccharides (GAGs) may support joint and connective tissue health but oral bioavailability of intact GAG chains is limited, with most being partially degraded in the GI tract before absorption.

Preparation & Dosage

No clinically studied dosage ranges have been established for shark cartilage calcium in humans. Processing yields vary with liquid extracts containing 2.0 mg calcium/100g and solid extracts containing 114 mg/g calcium, but standardized dosing protocols are not available. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Vitamin D3, Magnesium, Vitamin K2, Phosphorus, Collagen

Safety & Interactions

Shark cartilage is generally tolerated at typical supplemental doses, but commonly reported side effects include nausea, vomiting, bloating, and hypercalcemia risk at high doses due to its significant calcium content. It is contraindicated during pregnancy and in individuals who have recently undergone surgery, as anti-angiogenic activity may impair wound healing and fetal vascular development. Potential interactions exist with calcium-channel blockers and anticoagulants, since high calcium intake can alter vascular tone regulation and chondroitin sulfate may potentiate warfarin's anticoagulant effect. Individuals with seafood or shellfish allergies should exercise caution due to potential cross-reactive marine-derived proteins.